2m 2m 2m 2m 2m 2m 2m
Integer Holdings (ITGR)
NYSE
$89.51-$0.59 (-0.65%)
Price as of Jun 23, 2026 4:15 PM EDT- $3.1BMarket Cap
- -24.33%1-Year Change
- Medical DevicesIndustry
Integer Holdings (ITGR)
$89.51-$0.59 (-0.65%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.9B +7.98% | 1.7B +7.51% | 1.6B +16.03% | 1.4B +12.70% | |
Cost of Revenue | 1.4B +7.61% | 1.3B +6.72% | 1.2B +15.86% | 1.0B +15.04% | |
Gross Profit | 500.4M +9.01% | 459.0M +9.74% | 418.3M +16.51% | 359.0M +6.54% | |
Sales and Marketing Expense | 211.7M +14.33% | 185.2M +5.46% | 175.6M +9.37% | 160.6M +13.55% | |
Research and Development Expense | -49.5M -7.35% | -53.4M -16.22% | -63.8M +4.68% | -60.9M +17.18% | |
Depreciation and Amortization Expense | 130.7M +17.69% | 111.0M +12.33% | 98.8M +7.45% | 92.0M +13.05% | |
Total Operating Expenses | 279.1M +11.30% | 250.8M -0.07% | 251.0M +5.59% | 237.7M +18.10% | |
Operating Profit | 221.3M +6.26% | 208.2M +24.45% | 167.3M +37.92% | 121.3M -10.60% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -53.4M +38.15% | -38.6M +22.14% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -53.4M +38.15% | -38.6M +22.14% | |
Total Nonoperating Income and Expense | -53.2M +1,411.28% | -3.5M +261.13% | -975,000 -208.45% | 899,000 +630.89% | |
Income before Taxes | 125.4M -15.02% | 147.6M +37.53% | 107.3M +41.25% | 76.0M -24.84% | |
Income Taxes | 22.6M -14.88% | 26.5M +59.28% | 16.6M +56.90% | 10.6M +31.89% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 102.8M -14.25% | 119.9M +32.26% | 90.7M +36.57% | 66.4M -31.43% | |
Net Income from Continuing Operations Applicable to Common | 125.4M -15.02% | 147.6M +62.78% | 90.7M +19.34% | 76.0M -24.84% | |
Basic EPS and Net Income | 2.96 -17.09% | 3.57 +31.25% | 2.72 +36.00% | 2.00 -31.74% | |
Diluted EPS and Net Income | 2.89 -13.99% | 3.36 +24.91% | 2.69 +35.18% | 1.99 -31.62% | |
Basic Weighted Average Shares | 34.7M +3.37% | 33.6M +0.84% | 33.3M +0.58% | 33.1M +0.41% | |
Diluted Weighted Average Shares | 35.6M -0.15% | 35.6M +5.60% | 33.8M +1.20% | 33.4M +0.30% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 17.2M -63.13% | 46.5M +96.60% | 23.7M -2.46% | 24.3M +35.71% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 17.2M -63.13% | 46.5M +96.60% | 23.7M -2.46% | 24.3M +35.71% | |
Total Current Assets | 770.1M +14.75% | 671.1M +8.65% | 617.7M +10.63% | 558.3M +23.25% | |
Accumulated Depreciation | 569.0M +13.31% | 502.2M +4.91% | 478.7M +9.28% | 438.0M +7.81% | |
Property and Plant and Equipment and Net | 536.4M +15.16% | 465.8M +14.18% | 408.0M +28.59% | 317.2M +14.49% | |
Total Long-Term Assets | 23.2M +0.92% | 23.0M +2.42% | 22.4M -16.53% | 26.9M -38.76% | |
Total Assets | 3.4B +10.81% | 3.1B +4.60% | 2.9B +5.31% | 2.8B +8.22% | |
Income Taxes Payable | 116.3M -6.65% | 124.6M -16.66% | 149.5M -12.86% | 171.6M -0.37% | |
Total Short-Term Debt | 0 -100.00% | 10.0M N/A | 0 -100.00% | 18.2M +19.27% | |
Total Current Liabilities | 232.0M +2.14% | 227.2M +2.81% | 221.0M -1.24% | 223.8M +40.17% | |
Total Long-Term Debt | 1.2B +20.92% | 980.2M +2.11% | 959.9M +5.83% | 907.1M +11.59% | |
Total Long-Term Liabilities | 19.9M -21.49% | 25.4M +76.54% | 14.4M +7.37% | 13.4M -43.65% | |
Total Liabilities | 1.7B +14.07% | 1.5B +2.47% | 1.4B +3.39% | 1.4B +12.17% | |
Retained Earnings | 994.1M +11.54% | 891.2M +15.54% | 771.4M +13.32% | 680.7M +10.80% | |
Total Stockholders Equity | 1.7B +7.87% | 1.6B +6.59% | 1.5B +7.17% | 1.4B +4.63% | |
Total Shares Outstanding | 34.3M +2.39% | 33.5M +0.65% | 33.3M +0.48% | 33.2M +0.32% | |
Cash Flow | |||||
Cash from Operating Activities | 196.1M -4.41% | 205.2M +13.87% | 180.2M +54.85% | 116.4M -25.71% | |
Capital Expenditures | 91.0M -13.60% | 105.4M -12.16% | 119.9M +60.50% | 74.7M +39.78% | |
Cash from Investing Activities | -270.7M +38.54% | -195.4M +19.62% | -163.4M -18.49% | -200.4M -26.04% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 43.6M +226.99% | 13.3M +173.95% | -18.0M -119.48% | 92.5M +12.79% | |
Financials Ratio | |||||
Gross Margin | 26.99% +0.95% | 26.74% +2.07% | 26.20% +0.42% | 26.09% -5.46% | |
Operating Margin | 11.94% -1.60% | 12.13% +15.75% | 10.48% +18.86% | 8.82% -20.67% | |
Return on Assets | 3.17% -20.44% | 3.98% +26.03% | 3.16% +27.99% | 2.47% -36.82% | |
Return on Equity | 6.11% -20.05% | 7.64% +23.76% | 6.17% +28.93% | 4.79% -35.06% | |
Revenue Growth | 7.98% +6.29% | 7.51% -53.14% | 16.03% +26.26% | 12.70% -7.70% | |
Current Ratio | 3.32 +12.34% | 2.95 +5.68% | 2.80 +12.03% | 2.50 -12.07% | |
Cash Ratio | 0.07 -63.88% | 0.20 +91.32% | 0.11 -1.29% | 0.11 -3.12% | |
Debt-to-Equity Ratio | 0.68 +10.96% | 0.61 -3.23% | 0.63 -3.20% | 0.65 +6.79% | |
Debt-to-Assets Ratio | 0.35 +8.02% | 0.32 -1.38% | 0.33 -1.48% | 0.33 +3.24% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow